Increased RPA1 Gene Dosage Affects Genomic Stability Potentially Contributing to 17p13.3 Duplication Syndrome
2011

Increased RPA1 Gene Dosage Affects Genomic Stability

publication Evidence: moderate

Author Information

Author(s): Emily Outwin, Gillian Carpenter, Weimin Bi, Marjorie A. Withers, James R. Lupski, Mark O'Driscoll

Primary Institution: University of Sussex

Hypothesis

Does increased dosage of the RPA1 gene affect genomic stability and contribute to 17p13.3 Duplication Syndrome?

Conclusion

Increased RPA1 gene dosage is associated with genomic instability and sensitivity to DNA damage.

Supporting Evidence

  • Cell lines from patients with RPA1 duplications show abnormal DNA damage response.
  • Increased RPA1 levels are linked to genomic instability and sensitivity to DNA damaging agents.
  • Modest over-expression of RPA1 affects homologous recombination pathways.

Takeaway

Having too much of a certain gene, RPA1, can make cells unstable and more likely to get damaged.

Methodology

The study used patient-derived lymphoblastoid cell lines and various model systems to analyze the effects of RPA1 over-expression on DNA damage response and genomic stability.

Limitations

The study primarily focuses on specific cell lines and may not fully represent the complexity of in vivo conditions.

Digital Object Identifier (DOI)

10.1371/journal.pgen.1002247

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication